22 BOSTON WHARF ROAD, BOSTON, MA
Market cap: $4.6K (12/18/2025)
Price: $0.26
Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market
Shareholder Vote Results from Akari Therapeutics Special Meeting
Investor Presentation
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Interim CFO Appointment - Kameel Farag Named Chief Financial Officer
Akari Therapeutics Enters Into Securities Purchase Agreement for ADSs
Akari Therapeutics Announces $2.5 Million Registered Direct Offering
Other Events
Q3
Q1
FY 2024
Notice of Late Filing for Annual Report
Notice of Late Filing for Quarterly Report
Q2
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement
Post-Effective Amendment to a Registration Statement for Depositary Shares